Courtney Flaherty - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Courtney Flaherty's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Courtney Flaherty
Verified
Assistant Editor, OncLive
Trenton
Beats
musicHealthcare general interest travel
Immoral topics
Content
Molecular Profiling, Endocrine Sensitivity Are Key to Managing Later-Line HR+/HER2-Negative Breast Cancer
By Courtney Flaherty Verified| OncLive Verified Although the combination of an aromatase inhibitor (AI) and a CDK4/6 inhibitor remains the standard of care for frontline management of advanced hormone receptor (HR)–positive, HER2-negative breast cancer, an increasing reliance on molecular profiling and the lack of predictive tools to reliably stratify patients according to endocrine sensitivity continue to complicate treatment selection and sequencing in the second-line and beyond, particularly as more effective agents become available in...
By Courtney Flaherty Verified| OncLive Verified Treatment with bexmarilimab (FP-1305) plus standard-of-care (SOC) azacitidine elicited overall responses in patients with relapsed/refractory higher-risk myelodysplastic syndrome (MDS), meeting the primary end point of the phase 2 BEXMAB trial (NCT05428969).1 Additionally, patients with treatment-naive higher-risk MDS treated on the study also experienced a high level of response.
Pembrolizumab Plus Concurrent Chemoradiation Represents New SOC for High-Risk, Locally Advanced Cervical Cancer
By Courtney Flaherty Verified| OncLive Verified Findings from the phase 3 KEYNOTE-A18 trial (NCT04221945) showed that adding pembrolizumab (Keytruda) to concurrent chemoradiotherapy improved overall survival (OS) and time to second disease progression or death (PFS2) without introducing new safety concerns in patients with newly diagnosed, high-risk, locally advanced cervical cancer, supporting its use as a new standard of care for a patient population that has experienced longstanding treatment challenges, according to Linda R.
Company Info
OncLive
NeurologyLive is a multimedia platform focused on delivering the latest news and insights in the field of neurology. It serves as a valuable resource for healthcare professionals, particularly those treating neurological diseases. The platform offers a combination of print and digital media, ensuring that busy clinicians stay informed about significant developments in neurology. The services provided by NeurologyLive include breaking news on drug approvals, clinical trials, and emerging trends in neurological care. It features expert interviews with leading neurologists, offering insights into the latest research and clinical practices. The use of multimedia content makes the information accessible and engaging for its audience. NeurologyLive targets healthcare professionals such as neurologists, clinicians, and researchers. It has established strategic partnerships with organizations like the Consortium of Multiple Sclerosis Centers, enhancing its credibility and reach within the neurology community. Its comprehensive coverage and expert engagement position NeurologyLive as a trusted source for the latest developments in the field.
Cranbury, United States
+1 609-716-7777
Founded: 2018